Marcelo Augusto Szymanski de Toledo

8PUBLICATIONS
65CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)BiofabricationHaematological tumoursCarbon capture engineering (excl. sequestration)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 24, 2026
Selective dependency of CALR-mutant myeloproliferative neoplasms on TYK2 signaling.

|May 07, 2026
CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosis.

|Feb 06, 2026
Allogeneic Immune Cell Perfusion Inhibits the Growth of Vascularized 3D In Vitro Tumor Models, Induces Vascular Regression and Desmoplasia, but Promotes Tumor Cell Invasion.

Alexandra Raab, Rasika Daware, Marcelo A Szymanski de Toledo

|Nov 13, 2024
Cell Adhesion and Local Cytokine Control on Protein-Functionalized PNIPAM-co-AAc Hydrogel Microcarriers.

Sebastian Bernhard Rauer, Lucas Stüwe, Lea Steinbeck

|Jun 17, 2024
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment.

Dominik Schmidt, Cornelia Endres, Rouven Hoefflin

|Dec 23, 2023
Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms.

Max Bermes, Maria Jimena Rodriguez, Marcelo Augusto Szymanski de Toledo

Pageof 2

Frequent Collaborators

5 joint publications

Steffen Koschmieder

2 joint publications

Nicolas Chatain

2 joint publications

Julian Baumeister

1 joint publications

John Linkhorst